What should personalized, precision treatment of cancer look like in the future?
We know that people are different, their tumors are different, and they respond differently to different therapies. Medical teams of the future might be able to create a ?“virtual twin” of a person and their tumor. Then, by tapping supercomputers, physician-led teams could simulate how tumor cells behave to test millions (or billions) of possible treatment combinations. Ultimately, the best combinations might offer clues towards a personalized, effective treatment plan.
Sound like wishful thinking? The first steps towards this vision have been undertaken by a multi-institution research collaboration that includes Jonathan Ozik and Nicholson Collier, computational scientists at the U.S. Department of Energy’s Argonne National Laboratory.
The research team, which includes collaborators at Indiana University and the University of Vermont Medical Center, brought the power of high-performance computing to the thorny challenge of improving cancer immunotherapy. The team tapped twin supercomputers at Argonne and the University of Chicago, finding that high-performance computing can yield clues in fighting cancer, as discussed in a June 7 article published in Molecular Systems Design and Engineering.
“With this new approach, researchers can use agent-based modeling in more scientifically robust ways.” — Nicholson Collier, computational scientist at Argonne and the University of Chicago
Standing up to cancer
Cancer immunotherapy is a promising treatment that realigns your immune system to reduce or eliminate cancer cells. The therapy, however, helps only 10 to 20 percent of patients — partly because the way in which cancer cells and immune cells mingle is complex and poorly understood. Proven rules are scarce.
To begin uncovering the rules of immunotherapy, the team turned to a set of three tools:
- Agent-based modeling, which predicted the behavior of individual ?“agents” – cancer and immune cells, in this case
- Argonne’s award-winning workflow technology to take full advantage of the supercomputers
- A guiding framework to explore models and dynamically direct and track results
The trio operate in a hierarchy. The framework, developed by Ozik, Collier, Argonne colleagues, and Gary An, a surgeon and professor at the University of Vermont Medical Center, is called Extreme-scale Model Exploration with Swift (EMEWS). It oversees the agent-based model and the workflow system, the Swift/T parallel scripting language, developed at Argonne and the University of Chicago.
What is unique about this combination of tools? ?“We are helping more people in a variety of computational science fields to do large-scale experimentation with their models,” said Ozik, who — like Collier — holds a joint appointment at the University of Chicago. ?“Building a model is fun. But without supercomputers, it is difficult to really understand the full potential of how models can behave.”
The Latest on: Personalized medicine
via Google News
The Latest on: Personalized medicine
- Exscientia AI study spots which blood cancer therapies work and which don’ton October 14, 2021 at 8:27 am
Using AI in personalized medicine could boost treatment success in patients with aggressive blood cancers, an Exscientia study found. The method follows a basic idea: Take a test to see whether a drug ...
- At initial cancer diagnosis, a deeply personalized assessmenton October 13, 2021 at 3:12 pm
UC San Diego researchers report that conducting genomic evaluations of advanced malignancies can be effective in guiding first-line-of-treatment, rather than waiting until standard-of-care therapies ...
- At initial cancer diagnosis, a deeply personalized assessment can help guide treatment planon October 13, 2021 at 1:40 pm
In treating cancer, personalized medicine means recognizing that the same disease can behave differently from one patient to another, and precision medicine means that diagnosis and treatment should ...
- CTI Announces Contract Development and Manufacturing Initiative During Alliance for Regenerative Medicine Meeting on the Mesaon October 13, 2021 at 1:36 pm
CTI Clinical Trial and Consulting Services (CTI), a global, privately held, full-service contract research organization announced plans today to offer contract development and manufacturing services.
- Personalized medicine: Platform enables comparative research on cancerous tumorson October 12, 2021 at 7:07 am
Researchers have developed an algorithm that enhances the ability to compare tumors between different patients, overcoming high inter-patient variability.
- New federated analytics system can act as a game-changer towards personalized medicineon October 11, 2021 at 9:43 pm
Predictive, preventive, personalized and participatory medicine, known as P4, is the healthcare of the future. To both accelerate its adoption and maximize its potential, clinical data on large ...
- Study suggests personalized medicine may be the future of Alzheimer's disease treatmenton October 8, 2021 at 9:34 am
A recently released paper from the Department of Physiology and Sanders-Brown Center on Aging (SBCoA) at the University of Kentucky College of Medicine suggests that your genetics can influence your ...
- Global DNA & RNA Banking Services Markets, 2021-2028 - Shifting Focus Towards Personalized Medicine and Genetic Testingon October 7, 2021 at 9:15 am
The "Global DNA & RNA Banking Services Market Size, Share & Trends Analysis Report by Service Type (Storage Service, ...
- Gene Expression Market Growth Driven by Rising Need for Personalized Medicine: Reports and Dataon October 7, 2021 at 12:22 am
The global gene expression market revenue growth is majorly supported by factors such as rising prevalence of chronic and acute diseases, growing need for advanced cancer therapeutics, rising adoption ...
- Personalized Medicine Market Will Touch New Height In Upcoming Years, Key Players -Agendia NV, Amgen Inc.on October 6, 2021 at 6:47 am
Don’t Miss out the opportunity. New York, United States : Latest report published by Decisive Markets Insights on Personalized Medicine Market has only 20 licensed copies left with us. We would ...
via Bing News